Christopher Linthwaite and Gajus Worthington

Fluidigm has appointed Christopher Linthwaite as CEO and member of the board of directors. He succeeds Gajus Worthington, who has stepped down from his positions as CEO and board member. Linthwaite joined Fluidigm as president and chief operating officer earlier this year. He has also served as a senior business executive with Invitrogen, Life Technologies, and Thermo Fisher Scientific.

Michael Kamdar

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.